Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology research

FHS
May 1, 2024
2:19 pm

84% of Patients Would Participate in a Hospital-at-Home Program

What You Should Know: – As waivers allowing in-home patient care expire this year, a new survey by Vivalink, a leader in digital healthcare solutions,

June 14, 2024

Rare condition post-orgasmic illness syndrome explored in depth

Comprehensive review synthesizes current knowledge on post-orgasmic illness syndrome (POIS), a rare condition marked by a range of symptoms following ejaculation, highlighting the need for

March 18, 2024

Coherus BioSciences to acquire Surface Oncology for $65m

Surface Oncology’s SRF388 is being assessed as a monotherapy and in combination with checkpoint inhibitors in Phase II clinical trials to treat lung cancer and

June 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.